These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 38650654)
1. Inhibition of SUV39H1 reduces tumor angiogenesis via Notch1 in oral squamous cell carcinoma. Chen Y; Weng X; Zhang C; Wang S; Wu X; Cheng B PeerJ; 2024; 12():e17222. PubMed ID: 38650654 [TBL] [Abstract][Full Text] [Related]
2. Anti-cancer effect of genistein in oral squamous cell carcinoma with respect to angiogenesis and in vitro invasion. Myoung H; Hong SP; Yun PY; Lee JH; Kim MJ Cancer Sci; 2003 Feb; 94(2):215-20. PubMed ID: 12708500 [TBL] [Abstract][Full Text] [Related]
3. RNAi-mediated downregulation of oral cancer overexpressed 1 (ORAOV1) inhibits vascular endothelial cell proliferation, migration, invasion, and tube formation. Zhao X; Liu D; Wang L; Wu R; Zeng X; Dan H; Ji N; Jiang L; Zhou Y; Chen Q J Oral Pathol Med; 2016 Apr; 45(4):256-61. PubMed ID: 26449957 [TBL] [Abstract][Full Text] [Related]
4. Semaphorin 4A restricts tumor progression by inhibiting angiogenesis of oral squamous cell carcinoma cells. Liu XQ; Yao Y; Mu JW; Yang FY Tissue Cell; 2021 Apr; 69():101485. PubMed ID: 33460983 [TBL] [Abstract][Full Text] [Related]
5. Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma. Shinriki S; Jono H; Ota K; Ueda M; Kudo M; Ota T; Oike Y; Endo M; Ibusuki M; Hiraki A; Nakayama H; Yoshitake Y; Shinohara M; Ando Y Clin Cancer Res; 2009 Sep; 15(17):5426-34. PubMed ID: 19706815 [TBL] [Abstract][Full Text] [Related]
6. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells. Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis. Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854 [TBL] [Abstract][Full Text] [Related]
9. Eldecalcitol (ED-71), an analog of 1α,25(OH) Shintani T; Takatsu F; Rosli SNZ; Usui E; Hamada A; Sumi K; Hayashido Y; Toratani S; Okamoto T In Vitro Cell Dev Biol Anim; 2017 Oct; 53(9):810-817. PubMed ID: 28710602 [TBL] [Abstract][Full Text] [Related]
10. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression. Shang ZJ; Li JR J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226 [TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-β signals promote progression of squamous cell carcinoma by inducing epithelial-mesenchymal transition and angiogenesis. Ibi H; Takahashi K; Harada H; Watabe T; Podyma-Inoue KA Biochem Biophys Res Commun; 2024 Jun; 714():149965. PubMed ID: 38657447 [TBL] [Abstract][Full Text] [Related]
12. Expression of pro-inflammatory protein, iNOS, VEGF and COX-2 in oral squamous cell carcinoma (OSCC), relationship with angiogenesis and their clinico-pathological correlation. Sappayatosok K; Maneerat Y; Swasdison S; Viriyavejakul P; Dhanuthai K; Zwang J; Chaisri U Med Oral Patol Oral Cir Bucal; 2009 Jul; 14(7):E319-24. PubMed ID: 19300368 [TBL] [Abstract][Full Text] [Related]
13. Angiopoietin-2 expression is correlated with angiogenesis and overall survival in oral squamous cell carcinoma. Li C; Sun CJ; Fan JC; Geng N; Li CH; Liao J; Mi K; Zhu GQ; Ma H; Song YF; Tang YL; Chen Y Med Oncol; 2013; 30(2):571. PubMed ID: 23649549 [TBL] [Abstract][Full Text] [Related]
14. WISP-1 a novel angiogenic regulator of the CCN family promotes oral squamous cell carcinoma angiogenesis through VEGF-A expression. Chuang JY; Chen PC; Tsao CW; Chang AC; Lein MY; Lin CC; Wang SW; Lin CW; Tang CH Oncotarget; 2015 Feb; 6(6):4239-52. PubMed ID: 25738362 [TBL] [Abstract][Full Text] [Related]
15. Hujanen R; Salo T; Eklund KK; Salem A Anticancer Res; 2024 Jun; 44(6):2377-2392. PubMed ID: 38821582 [TBL] [Abstract][Full Text] [Related]
17. The pathological significance of Notch1 in oral squamous cell carcinoma. Yoshida R; Nagata M; Nakayama H; Niimori-Kita K; Hassan W; Tanaka T; Shinohara M; Ito T Lab Invest; 2013 Oct; 93(10):1068-81. PubMed ID: 23938602 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the anti-tumor and anti-angiogenic effect of paclitaxel and thalidomide on the xenotransplanted oral squamous cell carcinoma. Myoung H; Hong SD; Kim YY; Hong SP; Kim MJ Cancer Lett; 2001 Feb; 163(2):191-200. PubMed ID: 11165754 [TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor inhibition reduces angiogenesis via hypoxia-inducible factor-1α and Notch1 in head neck squamous cell carcinoma. Wang WM; Zhao ZL; Ma SR; Yu GT; Liu B; Zhang L; Zhang WF; Kulkarni AB; Sun ZJ; Zhao YF PLoS One; 2015; 10(2):e0119723. PubMed ID: 25723392 [TBL] [Abstract][Full Text] [Related]
20. Activin A triggers angiogenesis via regulation of VEGFA and its overexpression is associated with poor prognosis of oral squamous cell carcinoma. Ervolino De Oliveira C; Dourado MR; Sawazaki-Calone Í; Costa De Medeiros M; Rossa Júnior C; De Karla Cervigne N; Esquiche León J; Lambert D; Salo T; Graner E; Coletta RD Int J Oncol; 2020 Jul; 57(1):364-376. PubMed ID: 32377747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]